|

CTS2190 capsules Clinical Trials

1 actively recruiting trial

Also known as: CTS2190

Pipeline

Phase 1/2: 1

Top Sponsors

  • CytosinLab Therapeutics Co., Ltd.1

Indications

  • Solid Tumors1
  • Triple Negative Breast Cancer1
  • Pancreatic Cancer1
  • Lung Cancer1
  • Breast Cancer1

Other1 trial

CTS2190 Phase I /II Clinical Study in Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.